Pulmonary hypertension in two patients treated with bevacizumab for recurrent ovarian cancer

被引：10
|
作者：
Liotta, Margaret [1 ]
Rose, Peter G. [1 ]
Escobar, Pedro F. [1 ]
机构：
[1] Cleveland Clin, Div Gynecol Oncol, Dept Obstet & Gynecol, Cleveland, OH 44106 USA
来源：
GYNECOLOGIC ONCOLOGY | 2009年 / 115卷 / 02期
关键词：
Ovarian cancer; Pulmonary hypertentsion; Bevacizumab;
D O I：
10.1016/j.ygyno.2009.08.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：308 / 309
页数：2
相关论文
共 50 条
  • [1] Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab
    Schultheis, Anne M.
    Lurje, Georg
    Rhodes, Katrin E.
    Zhang, Wu
    Yang, Dongyun
    Garcia, Agustin A.
    Morgan, Robert
    Gandara, David
    Scudder, Sidney
    Oza, Amit
    Hirte, Hal
    Fleming, Gini
    Roman, Lynda
    Lenz, Heinz-Josef
    CLINICAL CANCER RESEARCH, 2008, 14 (22) : 7554 - 7563
  • [2] Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer treated with bevacizumab?
    Richardson, D. L.
    Backes, F. J.
    Hurt, J. D.
    Seamon, L. G.
    Copeland, L. J.
    Fowler, J. M.
    Cohn, D. E.
    O'Malley, D. M.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S23 - S23
  • [3] Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy
    Ventriglia, Jole
    Paciolla, Immacolata
    Pisano, Carmela
    Tambaro, Rosa
    Cecere, Sabrina Chiara
    Di Napoli, Marilena
    Attademo, Laura
    Arenare, Laura
    Spina, Anna
    Russo, Daniela
    Califano, Daniela
    Losito, Nunzia Simona
    Setola, Sergio Venanzio
    Franzese, Elisena
    De Vita, Ferdinando
    Orditura, Michele
    Pignata, Sandro
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 110 - 113
  • [4] Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients
    Fuh, Katherine C.
    Secord, Angeles A.
    Bevis, Kerri S.
    Huh, Warner
    ElNaggar, Adam
    Blansit, Kevin
    Previs, Rebecca
    Tillmanns, Todd
    Kapp, Daniel S.
    Chan, John K.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 413 - 418
  • [5] Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination
    Ryan M. Kahn
    Govind Ragupathi
    Qin C. Zhou
    Alexia Iasonos
    Sara Kravetz
    Martee L. Hensley
    Jason A. Konner
    Vicky Makker
    William P. Tew
    Carol Aghajanian
    Paul J. Sabbatini
    Roisin E. O’Cearbhaill
    Cancer Immunology, Immunotherapy, 2023, 72 : 183 - 191
  • [6] Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination
    Kahn, Ryan M.
    Ragupathi, Govind
    Zhou, Qin C.
    Iasonos, Alexia
    Kravetz, Sara
    Hensley, Martee L.
    Konner, Jason A.
    Makker, Vicky
    Tew, William P.
    Aghajanian, Carol
    Sabbatini, Paul J.
    O'Cearbhaill, Roisin E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (01) : 183 - 191
  • [7] The usefulness of bevacizumab for relief from symptomatic malignant ascites in patients with heavily treated recurrent ovarian cancer
    Shimizu, Yusuke
    Kajiyama, Hiroaki
    Yoshida, Kosuke
    Tamauchi, Satoshi
    Nakanishi, Toru
    Kikkawa, Fumitaka
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2019, 45 (12) : 2435 - 2439
  • [8] Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
    Richardson, D. L.
    Backes, F. J.
    Hurt, J. D.
    Seamon, L. G.
    Copeland, L. J.
    Fowler, J. M.
    Cohn, D. E.
    O'Malley, D. M.
    GYNECOLOGIC ONCOLOGY, 2010, 118 (01) : 47 - 51
  • [9] Bevacizumab toxicity in heavily pre-treated recurrent epithelial ovarian cancer
    Martin, I.
    Urban, R.
    Goff, B.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 197 - 197
  • [10] The efficacy and toxicity of bevacizumab plus genicitabine in patients with recurrent ovarian cancer
    Bevis, K. S.
    Numnum, T. M.
    Shipman, K. A.
    Makhija, S.
    Barnes, M. N.
    Straughn, J.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S119 - S120
12345